ID   INTU_HUMAN              Reviewed;         942 AA.
AC   Q9ULD6; A1L4N5; D6RAE6; D6RBT4; Q4W5I8; Q86V55;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2005, sequence version 2.
DT   18-JUN-2025, entry version 172.
DE   RecName: Full=Protein inturned;
DE   AltName: Full=Inturned planar cell polarity effector homolog;
DE   AltName: Full=PDZ domain-containing protein 6;
GN   Name=INTU; Synonyms=KIAA1284, PDZD6, PDZK6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10574462; DOI=10.1093/dnares/6.5.337;
RA   Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XV. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:337-345(1999).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Hippocampus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-674, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   INTERACTION WITH NPHP4 AND DAAM1, AND SUBCELLULAR LOCATION.
RX   PubMed=26644512; DOI=10.1083/jcb.201502043;
RA   Yasunaga T., Hoff S., Schell C., Helmstaedter M., Kretz O., Kuechlin S.,
RA   Yakulov T.A., Engel C., Mueller B., Bensch R., Ronneberger O., Huber T.B.,
RA   Lienkamp S.S., Walz G.;
RT   "The polarity protein Inturned links NPHP4 to Daam1 to control the
RT   subapical actin network in multiciliated cells.";
RL   J. Cell Biol. 211:963-973(2015).
RN   [9] {ECO:0007744|PDB:7Q3D}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.35 ANGSTROMS) OF 2-942, IDENTIFICATION
RP   IN THE CPLANE COMPLEX, CHARACTERIZATION OF VARIANT THR-452, AND
RP   CHARACTERIZATION OF VARIANT SRTD20 ALA-500.
RX   PubMed=35427153; DOI=10.1126/sciadv.abn0832;
RA   Langousis G., Cavadini S., Boegholm N., Lorentzen E., Kempf G.,
RA   Matthias P.;
RT   "Structure of the ciliogenesis-associated CPLANE complex.";
RL   Sci. Adv. 8:Eabn0832-Eabn0832(2022).
RN   [10]
RP   INVOLVEMENT IN OFD17; SRTD7/20 AND SRTD20, FUNCTION, INTERACTION WITH
RP   CPLANE1, VARIANT THR-452, VARIANTS SRTD20 355-GLU--LEU-942 DEL AND ALA-500,
RP   VARIANT SRTD7/20 276-GLN--LEU-942 DEL, AND CHARACTERIZATION OF VARIANTS
RP   SRTD20 355-GLU--LEU-942 DEL AND ALA-500.
RX   PubMed=27158779; DOI=10.1038/ng.3558;
RA   Toriyama M., Lee C., Taylor S.P., Duran I., Cohn D.H., Bruel A.L.,
RA   Tabler J.M., Drew K., Kelly M.R., Kim S., Park T.J., Braun D.A.,
RA   Pierquin G., Biver A., Wagner K., Malfroot A., Panigrahi I., Franco B.,
RA   Al-Lami H.A., Yeung Y., Choi Y.J., Duffourd Y., Faivre L., Riviere J.B.,
RA   Chen J., Liu K.J., Marcotte E.M., Hildebrandt F., Thauvin-Robinet C.,
RA   Krakow D., Jackson P.K., Wallingford J.B.;
RT   "The ciliopathy-associated CPLANE proteins direct basal body recruitment of
RT   intraflagellar transport machinery.";
RL   Nat. Genet. 48:648-656(2016).
CC   -!- FUNCTION: Plays a key role in ciliogenesis and embryonic development.
CC       Regulator of cilia formation by controlling the organization of the
CC       apical actin cytoskeleton and the positioning of the basal bodies at
CC       the apical cell surface, which in turn is essential for the normal
CC       orientation of elongating ciliary microtubules. Plays a key role in
CC       definition of cell polarity via its role in ciliogenesis but not via
CC       conversion extension. Has an indirect effect on hedgehog signaling (By
CC       similarity). Proposed to function as core component of the CPLANE
CC       (ciliogenesis and planar polarity effectors) complex involved in the
CC       recruitment of peripheral IFT-A proteins to basal bodies
CC       (PubMed:27158779). Required for recruitment of CPLANE2 to the mother
CC       centriole (By similarity). Binds phosphatidylinositol 3-phosphate with
CC       highest affinity, followed by phosphatidylinositol 4-phosphate and
CC       phosphatidylinositol 5-phosphate (By similarity).
CC       {ECO:0000250|UniProtKB:Q059U7, ECO:0000250|UniProtKB:Q2I0E5,
CC       ECO:0000305|PubMed:27158779}.
CC   -!- SUBUNIT: Component of the CPLANE (ciliogenesis and planar polarity
CC       effectors) complex, composed of INTU, FUZ and WDPCP (PubMed:35427153).
CC       Interacts with CPLANE1 (By similarity). Interacts with NPHP4 and DAAM1;
CC       INTU is mediating the interaction between NPHP4 and DAAM1
CC       (PubMed:26644512). {ECO:0000250|UniProtKB:Q059U7,
CC       ECO:0000269|PubMed:26644512, ECO:0000269|PubMed:35427153}.
CC   -!- INTERACTION:
CC       Q9ULD6; Q9Y4D1: DAAM1; NbExp=3; IntAct=EBI-11762696, EBI-2817289;
CC       Q9ULD6; Q9BT04: FUZ; NbExp=3; IntAct=EBI-11762696, EBI-750341;
CC       Q9ULD6; O75161: NPHP4; NbExp=2; IntAct=EBI-11762696, EBI-4281852;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q059U7}. Cell
CC       surface {ECO:0000250|UniProtKB:Q2I0E5}. Cytoplasm, cytoskeleton, cilium
CC       basal body {ECO:0000269|PubMed:26644512}. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome, centriole
CC       {ECO:0000250|UniProtKB:Q059U7}. Note=Enriched at the apical surface in
CC       ciliated cells. Localizes at the transition zone, a region between the
CC       basal body and the ciliary axoneme. Recruited to the centriole in a
CC       TTBK2-dependent manner. {ECO:0000250|UniProtKB:Q059U7,
CC       ECO:0000250|UniProtKB:Q2I0E5}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9ULD6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9ULD6-2; Sequence=VSP_015073, VSP_015074;
CC       Name=3;
CC         IsoId=Q9ULD6-3; Sequence=VSP_042586, VSP_042587;
CC       Name=4;
CC         IsoId=Q9ULD6-4; Sequence=VSP_042585;
CC   -!- DISEASE: Short-rib thoracic dysplasia 20 with polydactyly (SRTD20)
CC       [MIM:617925]: A form of short-rib thoracic dysplasia, a group of
CC       autosomal recessive ciliopathies that are characterized by a
CC       constricted thoracic cage, short ribs, shortened tubular bones, and a
CC       'trident' appearance of the acetabular roof. Polydactyly is variably
CC       present. Non-skeletal involvement can include cleft lip/palate as well
CC       as anomalies of major organs such as the brain, eye, heart, kidneys,
CC       liver, pancreas, intestines, and genitalia. Some forms of the disease
CC       are lethal in the neonatal period due to respiratory insufficiency
CC       secondary to a severely restricted thoracic cage, whereas others are
CC       compatible with life. Disease spectrum encompasses Ellis-van Creveld
CC       syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-
CC       Saldino syndrome, and short rib-polydactyly syndrome.
CC       {ECO:0000269|PubMed:27158779, ECO:0000269|PubMed:35427153}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Orofaciodigital syndrome 17 (OFD17) [MIM:617926]: A form of
CC       orofaciodigital syndrome, a group of heterogeneous disorders
CC       characterized by malformations of the oral cavity, face and digits, and
CC       associated phenotypic abnormalities that lead to the delineation of
CC       various subtypes. OFD17 inheritance is autosomal recessive.
CC       {ECO:0000269|PubMed:27158779}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Short-rib thoracic dysplasia 7/20 with polydactyly, digenic
CC       (SRTD7/20) [MIM:614091]: A digenic form of short-rib thoracic dysplasia
CC       caused by double heterozygosity for a mutation in the WDR35 gene and a
CC       mutation in the INTU gene. Short-rib thoracic dysplasia is part of a
CC       group of ciliopathies that are characterized by a constricted thoracic
CC       cage, short ribs, shortened tubular bones, and a 'trident' appearance
CC       of the acetabular roof. Polydactyly is variably present. Non-skeletal
CC       involvement can include cleft lip/palate as well as anomalies of major
CC       organs such as the brain, eye, heart, kidneys, liver, pancreas,
CC       intestines, and genitalia. Some forms of the disease are lethal in the
CC       neonatal period due to respiratory insufficiency secondary to a
CC       severely restricted thoracic cage, whereas others are compatible with
CC       life. Disease spectrum encompasses Ellis-van Creveld syndrome,
CC       asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino
CC       syndrome, and short rib-polydactyly syndrome. Note=The disease is
CC       caused by variants affecting distinct genetic loci, including the gene
CC       represented in this entry. SRTD7/20 can be caused by co-occurrence of
CC       WDR35 variant p.Trp311Leu and INTU p.Gln276Ter. One such patient has
CC       been reported. {ECO:0000269|PubMed:27158779}.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the inturned family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA86598.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB033110; BAA86598.1; ALT_INIT; mRNA.
DR   EMBL; AK291481; BAF84170.1; -; mRNA.
DR   EMBL; AC093591; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC097462; AAY41002.1; -; Genomic_DNA.
DR   EMBL; AC110797; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471056; EAX05202.1; -; Genomic_DNA.
DR   EMBL; BC051698; AAH51698.1; -; mRNA.
DR   EMBL; BC130611; AAI30612.1; -; mRNA.
DR   CCDS; CCDS34061.1; -. [Q9ULD6-1]
DR   RefSeq; NP_056508.2; NM_015693.3. [Q9ULD6-1]
DR   RefSeq; XP_011530148.1; XM_011531846.1.
DR   PDB; 7Q3D; EM; 3.35 A; B=2-942.
DR   PDBsum; 7Q3D; -.
DR   AlphaFoldDB; Q9ULD6; -.
DR   EMDB; EMD-13789; -.
DR   SMR; Q9ULD6; -.
DR   BioGRID; 118034; 50.
DR   ComplexPortal; CPX-5001; CPLANE complex.
DR   CORUM; Q9ULD6; -.
DR   FunCoup; Q9ULD6; 341.
DR   IntAct; Q9ULD6; 47.
DR   MINT; Q9ULD6; -.
DR   STRING; 9606.ENSP00000334003; -.
DR   GlyGen; Q9ULD6; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q9ULD6; -.
DR   PhosphoSitePlus; Q9ULD6; -.
DR   BioMuta; INTU; -.
DR   DMDM; 73621379; -.
DR   jPOST; Q9ULD6; -.
DR   MassIVE; Q9ULD6; -.
DR   PaxDb; 9606-ENSP00000334003; -.
DR   PeptideAtlas; Q9ULD6; -.
DR   ProteomicsDB; 84999; -. [Q9ULD6-1]
DR   ProteomicsDB; 85000; -. [Q9ULD6-2]
DR   ProteomicsDB; 85001; -. [Q9ULD6-3]
DR   ProteomicsDB; 85002; -. [Q9ULD6-4]
DR   Antibodypedia; 26899; 74 antibodies from 16 providers.
DR   DNASU; 27152; -.
DR   Ensembl; ENST00000335251.11; ENSP00000334003.5; ENSG00000164066.13. [Q9ULD6-1]
DR   Ensembl; ENST00000503626.5; ENSP00000426287.1; ENSG00000164066.13. [Q9ULD6-2]
DR   Ensembl; ENST00000503952.5; ENSP00000421995.1; ENSG00000164066.13. [Q9ULD6-3]
DR   GeneID; 27152; -.
DR   KEGG; hsa:27152; -.
DR   MANE-Select; ENST00000335251.11; ENSP00000334003.5; NM_015693.4; NP_056508.2.
DR   UCSC; uc003ifk.3; human. [Q9ULD6-1]
DR   AGR; HGNC:29239; -.
DR   CTD; 27152; -.
DR   DisGeNET; 27152; -.
DR   GeneCards; INTU; -.
DR   HGNC; HGNC:29239; INTU.
DR   HPA; ENSG00000164066; Tissue enhanced (retina).
DR   MalaCards; INTU; -.
DR   MIM; 610621; gene.
DR   MIM; 614091; phenotype.
DR   MIM; 617925; phenotype.
DR   MIM; 617926; phenotype.
DR   neXtProt; NX_Q9ULD6; -.
DR   OpenTargets; ENSG00000164066; -.
DR   PharmGKB; PA162392193; -.
DR   VEuPathDB; HostDB:ENSG00000164066; -.
DR   eggNOG; ENOG502QQJQ; Eukaryota.
DR   GeneTree; ENSGT00390000001301; -.
DR   HOGENOM; CLU_014223_0_1_1; -.
DR   InParanoid; Q9ULD6; -.
DR   OMA; CAGKSIS; -.
DR   OrthoDB; 10038586at2759; -.
DR   PAN-GO; Q9ULD6; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9ULD6; -.
DR   TreeFam; TF323932; -.
DR   PathwayCommons; Q9ULD6; -.
DR   Reactome; R-HSA-5610787; Hedgehog 'off' state.
DR   SignaLink; Q9ULD6; -.
DR   BioGRID-ORCS; 27152; 9 hits in 1159 CRISPR screens.
DR   ChiTaRS; INTU; human.
DR   GenomeRNAi; 27152; -.
DR   Pharos; Q9ULD6; Tbio.
DR   PRO; PR:Q9ULD6; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q9ULD6; protein.
DR   Bgee; ENSG00000164066; Expressed in right uterine tube and 161 other cell types or tissues.
DR   ExpressionAtlas; Q9ULD6; baseline and differential.
DR   GO; GO:0009986; C:cell surface; IEA:UniProtKB-SubCell.
DR   GO; GO:0005814; C:centriole; IEA:UniProtKB-SubCell.
DR   GO; GO:0036064; C:ciliary basal body; IDA:HPA.
DR   GO; GO:0035869; C:ciliary transition zone; IEA:Ensembl.
DR   GO; GO:0005929; C:cilium; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0031514; C:motile cilium; IDA:UniProtKB.
DR   GO; GO:0035091; F:phosphatidylinositol binding; ISS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:Ensembl.
DR   GO; GO:0060271; P:cilium assembly; ISS:UniProtKB.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IMP:GO_Central.
DR   GO; GO:0001736; P:establishment of planar polarity; NAS:ComplexPortal.
DR   GO; GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl.
DR   GO; GO:0042073; P:intraciliary transport; NAS:ComplexPortal.
DR   GO; GO:0030216; P:keratinocyte differentiation; IEA:Ensembl.
DR   GO; GO:0060173; P:limb development; ISS:UniProtKB.
DR   GO; GO:0044458; P:motile cilium assembly; IEA:Ensembl.
DR   GO; GO:0051782; P:negative regulation of cell division; IEA:Ensembl.
DR   GO; GO:0010839; P:negative regulation of keratinocyte proliferation; IEA:Ensembl.
DR   GO; GO:0007399; P:nervous system development; ISS:UniProtKB.
DR   GO; GO:0021915; P:neural tube development; NAS:ComplexPortal.
DR   GO; GO:1905515; P:non-motile cilium assembly; IEA:Ensembl.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl.
DR   GO; GO:0033365; P:protein localization to organelle; IEA:Ensembl.
DR   GO; GO:1902017; P:regulation of cilium assembly; NAS:ComplexPortal.
DR   GO; GO:0030278; P:regulation of ossification; IEA:Ensembl.
DR   GO; GO:0008589; P:regulation of smoothened signaling pathway; ISS:UniProtKB.
DR   GO; GO:0060021; P:roof of mouth development; IMP:GO_Central.
DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:Ensembl.
DR   GO; GO:0021513; P:spinal cord dorsal/ventral patterning; IEA:Ensembl.
DR   GO; GO:0043587; P:tongue morphogenesis; IMP:GO_Central.
DR   GO; GO:0016192; P:vesicle-mediated transport; IEA:InterPro.
DR   FunFam; 2.30.42.10:FF:000196; Inturned planar cell polarity protein; 1.
DR   Gene3D; 2.30.42.10; -; 1.
DR   InterPro; IPR043987; CCZ1/INTU/HSP4_longin_1.
DR   InterPro; IPR043989; CCZ1/INTU/HSP4_longin_3.
DR   InterPro; IPR043988; CCZ1/INTU_longin_2.
DR   InterPro; IPR039151; INTU.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   PANTHER; PTHR21082; PROTEIN INTURNED; 1.
DR   PANTHER; PTHR21082:SF4; PROTEIN INTURNED; 1.
DR   Pfam; PF19031; Intu_longin_1; 1.
DR   Pfam; PF19032; Intu_longin_2; 1.
DR   Pfam; PF19033; Intu_longin_3; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF50156; PDZ domain-like; 1.
DR   PROSITE; PS50106; PDZ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell projection; Ciliopathy;
KW   Cilium biogenesis/degradation; Cytoplasm; Cytoskeleton;
KW   Developmental protein; Disease variant; Phosphoprotein;
KW   Proteomics identification; Reference proteome.
FT   CHAIN           1..942
FT                   /note="Protein inturned"
FT                   /id="PRO_0000058296"
FT   DOMAIN          185..263
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REGION          1..52
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          704..754
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        22..31
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        37..46
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         670
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:D4ACE5"
FT   MOD_RES         674
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..49
FT                   /note="MASVASCDSRPSSDELPGDPSSQEEDEDYDFEDRVSDSGSYSSASSDYD ->
FT                   MFQVGRSSIPKPAPRSLEDLDSVQRVLLHS (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_042585"
FT   VAR_SEQ         395..408
FT                   /note="VPLPRLRNMIENVI -> IELPSSAHTHGERN (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_015073"
FT   VAR_SEQ         409..942
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_015074"
FT   VAR_SEQ         421..435
FT                   /note="AFCQIENVPRLDHFF -> IMKEFSVIVSSGKII (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_042586"
FT   VAR_SEQ         436..942
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_042587"
FT   VARIANT         276..942
FT                   /note="Missing (in SRTD7/20; in an SRTD7/20 patient who
FT                   also carries variant WDR35 L-311)"
FT                   /evidence="ECO:0000269|PubMed:27158779"
FT                   /id="VAR_080710"
FT   VARIANT         355..942
FT                   /note="Missing (in SRTD20; loss of subcellular location to
FT                   cilium basal body, when tested in a heterologous system)"
FT                   /evidence="ECO:0000269|PubMed:27158779"
FT                   /id="VAR_080711"
FT   VARIANT         452
FT                   /note="A -> T (no effect on the assembly of the CPLANE
FT                   complex; dbSNP:rs150681845)"
FT                   /evidence="ECO:0000269|PubMed:27158779,
FT                   ECO:0000269|PubMed:35427153"
FT                   /id="VAR_076782"
FT   VARIANT         500
FT                   /note="E -> A (in SRTD20; uncertain significance; impairs
FT                   recruitment of IFT43 to the basal body, but no effect on
FT                   subcellular location, when tested in a heterologous system;
FT                   no effect on the assembly of the CPLANE complex;
FT                   dbSNP:rs1360128571)"
FT                   /evidence="ECO:0000269|PubMed:27158779,
FT                   ECO:0000269|PubMed:35427153"
FT                   /id="VAR_076783"
FT   STRAND          308..313
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   STRAND          320..322
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   TURN            323..326
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   STRAND          327..331
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   HELIX           335..342
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   HELIX           344..357
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   STRAND          358..360
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   STRAND          362..369
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   STRAND          372..391
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   TURN            392..394
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   HELIX           397..415
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   HELIX           418..423
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   HELIX           425..427
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   HELIX           428..441
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   HELIX           445..447
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   HELIX           459..467
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   STRAND          470..472
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   HELIX           480..494
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   STRAND          513..521
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   STRAND          524..530
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   HELIX           532..544
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   HELIX           547..553
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   STRAND          559..565
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   STRAND          587..596
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   STRAND          599..608
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   HELIX           623..635
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   HELIX           639..647
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   STRAND          799..806
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   TURN            807..810
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   STRAND          811..813
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   HELIX           817..821
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   HELIX           828..859
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   STRAND          878..883
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   STRAND          903..909
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   STRAND          915..921
FT                   /evidence="ECO:0007829|PDB:7Q3D"
FT   HELIX           929..937
FT                   /evidence="ECO:0007829|PDB:7Q3D"
SQ   SEQUENCE   942 AA;  105648 MW;  F21BF6BC0EF7A8F8 CRC64;
     MASVASCDSR PSSDELPGDP SSQEEDEDYD FEDRVSDSGS YSSASSDYDD LEPEWLDSVQ
     KNGELFYLEL SEDEEESLLP ETPTVNHVRF SENEIIIEDD YKERKKYEPK LKQFTKILRR
     KRLLPKRCNK KNSNDNGPVS ILKHQSNQKT GVIVQQRYKD VNVYVNPKKL TVIKAKEQLK
     LLEVLVGIIH QTKWSWRRTG KQGDGERLVV HGLLPGGSAM KSGQVLIGDV LVAVNDVDVT
     TENIERVLSC IPGPMQVKLT FENAYDVKRE TSHPRQKKTQ SNTSDLVKLL WGEEVEGIQQ
     SGLNTPHIIM YLTLQLDSET SKEEQEILYH YPMSEASQKL KSVRGIFLTL CDMLENVTGT
     QVTSSSLLLN GKQIHVAYWK ESDKLLLIGL PAEEVPLPRL RNMIENVIQT LKFMYGSLDS
     AFCQIENVPR LDHFFNLFFQ RALQPAKLHS SASPSAQQYD ASSAVLLDNL PGVRWLTLPL
     EIKMELDMAL SDLEAADFAE LSEDYYDMRR LYTILGSSLF YKGYLICSHL PKDDLIDIAV
     YCRHYCLLPL AAKQRIGQLI IWREVFPQHH LRPLADSSTE VFPEPEGRYF LLVVGLKHYM
     LCVLLEAGGC ASKAIGSPGP DCVYVDQVKT TLHQLDGVDS RIDERLASSP VPCLSCADWF
     LTGSREKTDS LTTSPILSRL QGTSKVATSP TCRRTLFGDY SLKTRKPSPS CSSGGSDNGC
     EGGEDDGFSP HTTPDAVRKQ RESQGSDGLE ESGTLLKVTK KKSTLPNPFH LGNLKKDLPE
     KELEIYNTVK LTSGPENTLF HYVALETVQG IFITPTLEEV AQLSGSIHPQ LIKNFHQCCL
     SIRAVFQQTL VEEKKKGLNS GDHSDSAKSV SSLNPVKEHG VLFECSPGNW TDQKKAPPVM
     AYWVVGRLFL HPKPQELYVC FHDSVTEIAI EIAFKLFFGL TL
//
